Germany's Bayer and Onyx Pharmaceuticals (ONXX) said Monday that Tarceva in combination with Nexavar tablets for the treatment of hepatocellular carcinoma, a type of liver cancer, failed in further improvement of overall survival. Bayer and Onyx jointly produce Nexavar. Tarceva is sold by Astellas Pharma and Roche. Google Delivers Above-Consensus Profit
NRG Energy (NRG - Get Report) said Sunday it reached a deal to buy GenOn Energy (GEN) for $1.7 billion in stock. The merger creates the largest U.S. independent power producer. Microsoft Beats on Strength in Servers Business
Halliburton (HAL) is expected by analysts Monday to post second-quarter earnings of 75 cents a share on revenue of $6.93 billion.
Chipmaker Texas Instruments (TXN - Get Report), according to analysts, will post second-quarter profit of 41 cents a share on revenue of $3.35 billion. Texas Instruments posts numbers after Monday's closing bell.
Hasbro (HAS), the toy maker, is seen by analysts posting quarterly earnings on Monday of 24 cents a share on revenue of $832 million.
-- Written by Joseph Woelfel >To contact the writer of this article, click here: Joseph Woelfel >To submit a news tip, send an email to: email@example.com.